These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3486765)

  • 1. 2-Deoxy-2-[18F]fluoro-D-galactose: a new tracer for the measurement of galactose metabolism in the liver by positron emission tomography.
    Fukuda H; Matsuzawa T; Tada M; Takahashi T; Ishiwata K; Yamada K; Abe Y; Yoshioka S; Sato T; Ido T
    Eur J Nucl Med; 1986; 11(11):444-8. PubMed ID: 3486765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of 6-deoxy-6-[18F]fluoro-D-galactose as a PET tracer for studying galactose metabolism.
    Ishiwata K; Tomura M; Ido T; Iwata R; Itoh J; Kameyama M
    Int J Rad Appl Instrum B; 1989; 16(8):775-81. PubMed ID: 2621112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo.
    Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Friedrich E; Lehmann J; Keppler D
    Eur J Biochem; 1990 May; 190(1):11-9. PubMed ID: 2114284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.
    Grün BR; Berger U; Oberdorfer F; Hull WE; Ostertag H; Keppler D
    Adv Enzyme Regul; 1990; 30():231-42. PubMed ID: 2403033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Deoxy-2-[18F]fluoro-D-galactose as an in vivo tracer for imaging galactose metabolism in tumors with positron emission tomography.
    Ishiwata K; Yamaguchi K; Kameyama M; Fukuda H; Tada M; Matsuzawa T; Muraishi K; Itoh J; Kawashima K; Takahashi T
    Int J Rad Appl Instrum B; 1989; 16(3):247-54. PubMed ID: 2785512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of 2-deoxy-2-[18F]fluoro-D-galactose in the liver by phosphate and uridylate trapping.
    Ishiwata K; Ido T; Imahori Y; Yamaguchi K; Fukuda H; Tada M; Matsuzawa T
    Int J Rad Appl Instrum B; 1988; 15(3):271-6. PubMed ID: 3260229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
    J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2-Deoxy-2-(18F)Fluoro-D-galactose: a new tracer for the evaluation of liver function by PET--I. Evaluation of toxicity and radiation dose].
    Fukuda H; Yamaguchi K; Matsuzawa T; Abe Y; Yamada K; Yoshioka S; Sato T; Tada M; Ogata Y; Takahashi T
    Kaku Igaku; 1987 Feb; 24(2):165-9. PubMed ID: 3497290
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
    Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
    Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-[18F]fluoro-L-fucose: a possible tracer for assessing glycoconjugate synthesis in tumors with positron emission tomography.
    Ishiwata K; Tomura M; Ido T; Iwata R; Sato K; Hatazawa J; Kameyama M; Imahori Y
    J Nucl Med; 1990 Dec; 31(12):1997-2003. PubMed ID: 2266399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.
    Sørensen M; Munk OL; Mortensen FV; Olsen AK; Bender D; Bass L; Keiding S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G27-G36. PubMed ID: 18483186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High accumulation of 2-deoxy-2-fluorine-18-fluoro-D-galactose by well-differentiated hepatomas of mice and rats.
    Fukuda H; Takahashi J; Fujiwara T; Yamaguchi K; Abe Y; Kubota K; Sato T; Miyazawa H; Hatazawa J; Tada M
    J Nucl Med; 1993 May; 34(5):780-6. PubMed ID: 8478711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2-Deoxy-2-[18F]fluoro-D-galactose: a new probe for the evaluation of liver function by PET. II. A first clinical PET study of the liver in normal volunteers].
    Fukuda H; Yamaguchi K; Matsuzawa T; Itoh M; Abe Y; Fujiwara T; Yamaguchi T; Miyazawa H; Kawai H; Matsui H
    Kaku Igaku; 1987 Jun; 24(6):871-4. PubMed ID: 3500343
    [No Abstract]   [Full Text] [Related]  

  • 14. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
    Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
    J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biodistribution of a fluorine-18 labeled analogue of D-talose: 2-deoxy-2-[18F]fluoro-D-talose.
    Haradahira T; Kato A; Maeda M; Torii Y; Ichiya Y; Masuda K
    Int J Rad Appl Instrum A; 1992 May; 43(5):627-32. PubMed ID: 1325421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.
    Paul R; Aho K; Bergman J; Haaparanta M; Kulmala J; Reissell A; Solin O
    Int J Rad Appl Instrum B; 1989; 16(5):449-53. PubMed ID: 2509402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Villadsen GE; Keiding S
    J Hepatol; 2013 Jun; 58(6):1119-24. PubMed ID: 23339954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[
    Fode MM; Bak-Fredslund K; Petersen JB; Worm E; Sørensen M; Høyer M
    Acta Oncol; 2017 Nov; 56(11):1614-1620. PubMed ID: 28849688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
    Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
    Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic pathway of 2-deoxy-2-[18F]fluoro-D-talose in mice: trapping in tissue after phosphorylation by galactokinase.
    Haradahira T; Maeda M; Kato A; Kanazawa Y; Yamada M; Torii Y; Ichiya Y; Masuda K
    Nucl Med Biol; 1994 Feb; 21(2):269-76. PubMed ID: 9234293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.